Correction to: TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells

Zhijian Cai,Wei Zhang,Min Li,Yinpu Yue,Fei Yang,Lei Yu,Xuetao Cao,Jianli Wang

DOI: https://doi.org/10.1038/s41423-019-0338-6

2019-01-01

Abstract:n amendment to this paper has been published and can be accessed via a link at the top of the paper.

What problem does this paper attempt to address?

TGF-beta 1 gene -modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells (vol 7, pg 35, 2010)

Zhijian Cai,Wei Zhang,Min Li,Yinpu Yue,Fei Yang,Lei Yu,Xuetao Cao,Jianli Wang

DOI: https://doi.org/10.1038/s41423-019-0338-6

2020-01-01

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
TGF-|[bgr]|1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4|[plus]|Foxp3|[plus]| regulatory T cells

Zhijian Cai,Wei Zhang,Min Li,Yinpu Yue,Fei Yang,Lei Yu,Xuetao Cao,Jianli Wang

DOI: https://doi.org/10.1038/cmi.2009.107

2010-01-01

Abstract:Inflammatory bowel disease (IBD) is caused by an uncontrolled immune response in the intestinal lumen, leading to inflammation in genetically predisposed individuals. Immunotherapy may be a promising approach to the treatment of IBD. Here, we show that transforming growth factor-β1 (TGF-β1) gene-modified immature dendritic cells (imDCs) could enhance the inhibitory function of imDCs and delay the progress of IBD induced by dextran sodium sulfate in mice. The results of fluorescence-activated cell sorter (FACS) demonstrated that this protective effect is mediated partially by inducing CD4+Foxp3+ regulatory T cells (Tregs) in mesentery lymph nodes to control inflammation. In vitro experiments also supported this hypothesis. In conclusion, we provide evidence that TGF-β1-modified bone marrow-derived imDCs may have a therapeutic effect to IBD.
TGF-β1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4 + Foxp3 + regulatory T cells

Zhijian Cai,Wei Zhang,Min Li,Yinpu Yue,Fei Yang,Lei Yu,Xuetao Cao,Jianli Wang

DOI: https://doi.org/10.1038/cmi.2009.107

2010-01-01

Abstract:Inflammatory bowel disease (IBD) is caused by an uncontrolled immune response in the intestinal lumen, leading to inflammation in genetically predisposed individuals. Immunotherapy may be a promising approach to the treatment of IBD. Here, we show that transforming growth factor-β1 (TGF-β1) gene-modified immature dendritic cells (imDCs) could enhance the inhibitory function of imDCs and delay the progress of IBD induced by dextran sodium sulfate in mice. The results of fluorescence-activated cell sorter (FACS) demonstrated that this protective effect is mediated partially by inducing CD4 + Foxp3 + regulatory T cells (Tregs) in mesentery lymph nodes to control inflammation. In vitro experiments also supported this hypothesis. In conclusion, we provide evidence that TGF-β1-modified bone marrow-derived imDCs may have a therapeutic effect to IBD.
Correction: Bifidobacterium Adolescentis Induces Decorin+ Macrophages Via TLR2 to Suppress Colorectal Carcinogenesis

Yifeng Lin,Lina Fan,Yadong Qi,Chaochao Xu,Dingjiacheng Jia,Yao Jiang,Shujie Chen,Liangjing Wang

DOI: https://doi.org/10.1186/s13046-023-02796-w

IF: 12.658

2023-01-01

Journal of Experimental & Clinical Cancer Research

Abstract:BACKGROUND:The interplay between gut microbiota and tumor microenvironment (TME) in the pathogenesis of colorectal cancer (CRC) is largely unknown. Here, we elucidated the functional role of B. adolescentis and its possible mechanism on the manipulation of Decorin+ macrophages in colorectal cancer.METHODS:The relative abundance of B. adolescentis in tumor or para-tumor tissue of CRC patients was analyzed. The role of B. adolescentis was explored in the CRC animal models. The single cell-RNA sequencing (scRNA-seq) was used to investigate the myeloid cells subsets in TME. The expression level of TLR2/YAP axis and its downstream Decorin in macrophages were tested by Western blot and qRT-PCR. Knockdown of Decorin in Raw264.7 was performed to investigate the effect of Decorin+ macrophages on subcutaneous tumor formation. Multi-immunofluorescence assay examined the number of Decorin+ macrophages on the CRC tissue.RESULTS:We found that the abundance of B. adolescentis was significantly reduced in tumor tissue of CRC patients. Supplementation with B. adolescentis suppressed AOM/DSS-induced tumorigenesis in mice. ScRNA-seq and animal experiment revealed that B. adolescentis increased Decorin+ macrophages. Mechanically, Decorin was activated by TLR2/YAP axis in macrophages. The abundance of B. adolescentis was correlated with the number of Decorin+ macrophages and the expression level of TLR2 in tumor tissue of CRC patients.CONCLUSIONS:These results highlight that B. adolescentis induced Decorin+ macrophages and provide a novel therapeutic target for probiotic-based modulation of immune microenvironment in CRC.
Correction: Corrigendum: The transcriptional coactivator TAZ regulates reciprocal differentiation of T H 17 cells and T reg cells

Hao Zhao

DOI: https://doi.org/10.1038/ni1117-1270c

IF: 30.5

2017-01-01

Nature Immunology

Abstract:Nat. Immunol. 18, 800–812 (2017); published online 15 May 2017; corrected after print 20 July 2017 In the version of this article initially published, the description of Figure 1d,e in the first subsection of Results was incorrect; “...(Lck-Cre): Tazfl/flLck-Cre mice) immunized with KLH exhibited a larger TH17 population and fewer Treg cells than that of their Tazfl/fl littermates.
Correction To: TAOK1 Negatively Regulates IL-17-mediated Signaling and Inflammation

Zhaoru Zhang,Zhen Tang,Xianwei Ma,Kai Sun,Liping Fan,Jie Fang,Jianping Pan,Xiaojian Wang,Huazhang An,Jun Zhou

DOI: https://doi.org/10.1038/s41423-018-0048-5

2018-01-01

Abstract:In this article, published online 5 February 2018, the second primer of mouse actin, il-6, il-1β, TNFα, cxcl1, cxcl2, and ccl20 in Table 2 should be marked as “reverse primer” instead of “forward primer”. Corrected Table 2 is shown below. The authors regret the errors.
Correction: Transdifferentiation of Tumor Infiltrating Innate Lymphoid Cells During Progression of Colorectal Cancer

Shuo Wang,Yuan Qu,Pengyan Xia,Yi Chen,Xiaoxiao Zhu,Jing Zhang,Guan Wang,Tian Yong,Jianming Ying,Zusen Fan

DOI: https://doi.org/10.1038/s41422-020-0352-3

IF: 44.1

2020-01-01

Cell Research

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Correction to: Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice

Xiongjie Fu,Hanhai Zeng,Jikuang Zhao,Guoyang Zhou,Hang Zhou,Jianfeng Zhuang,Chaoran Xu,Jianru Li,Yucong Peng,Yang Cao,Yin Li,Huaijun Chen,Lin Wang,Feng Yan,Gao Chen

DOI: https://doi.org/10.1007/s12975-021-00919-z

2021-01-01

Translational Stroke Research

Abstract:Correction to this paper has been published: https://doi.org/10.1007/s12975-021-00919-z
TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.

Wenji Sun,Quanxing Wang,Lihuang Zhang,Jianping Pan,Min Zhang,Guohua Lu,Hangping Yao,Jianli Wang,Xuetao Cao

DOI: https://doi.org/10.1007/s00109-002-0346-2

2002-01-01

Abstract:Administration of donor-derived immature dendritic cells (DC) can prolong the survival of MHC-mismatched cardiac allografts. Genetic modification of DC by immunosuppressive molecules can enhance their potential tolerogenicity. In this study bone marrow derived immature DC were genetically modified by transforming growth factor (TGF) beta1 by recombinant Ad. TGF-beta(1) gene modified immature DC (TGF-beta-DC) displayed a characteristic phenotype of immature DC, decreased ability to secrete interleukin 12, and reduced allostimulatory ability. TGF-beta-DC induced alloantigen-specific T cell hyporesponsiveness in vitro and in vivo, and Th2 cytokine polarization. mRNA expression of donor MHC class II (Ia(b)) and human TGF-beta(1) was detected in spleen and lymph nodes of the allogeneic recipients for 3 weeks after TGF-beta-DC infusion, indicating that microchimerism of TGF-beta-DC is exhibited in allogeneic recipients. In this murine cervical heterotopic heart transplantation model, the survival of the allograft in recipients intravenously infused with TGF-beta-DC 7 days before transplantation was greatly prolonged, and about 67% of cardiac grafts survived more than 40 days. Histological analysis of the allografts showed that the normal myocardial architecture was well preserved, accompanied by very little necrotic cells, but interstitial fibrosis replaced myocytes, and moderate collagen suffused the whole cardiac allograft in the recipients infused with TGF-beta-DC. mRNA expression of type III procollagen was markedly increased in the allografts of the recipients infused with TGF-beta-DC. Our results suggest that infusion of TGF-beta(1) gene modified immature DC prolongs the survival of the allograft through the effective induction of donor-specific T cell hyporesponsiveness. However, TGF-beta(1) expressed by gene modified immature DC can cause the fibrosis of the allografts, which may limit the application of this approach in the allograft transplantation.
RETRACTED: Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes Dis DOI: 10.1016/J.gendis.2020.07.005]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Shi Feng,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2021.09.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.].
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Characterization of novel CD8+ regulatory T cells and their modulatory effects in murine model of inflammatory bowel disease

Jia-Ning Fan,Hsin Ho,Bor-Luen Chiang

DOI: https://doi.org/10.1007/s00018-024-05378-x

2024-08-01

Abstract:Dysregulation of mucosal immune system has been proposed to be critical in the pathogenesis of inflammatory bowel diseases (IBDs). Regulatory T cells (Tregs) play an important role in regulating immune responses. Tregs are involved in maintaining intestinal homeostasis and exerting suppressive function in colitis. Our previous studies showed that a novel forkhead box protein P3 (Foxp3) negative Tregs (Treg-of-B cells), induced by culturing naïve CD4+ T cells with B cells, could protect against colitis and downregulate T helper (Th) 1 and Th17 cell cytokines in T cell-mediated colitis. In the present study, we aimed to induce Treg-of-B cells in the CD8+ T-cell population and investigate their characteristics and immunomodulatory functions. Our results showed that CD8+ Treg-of-B cells expressed Treg-associated markers, including lymphocyte-activation gene-3 (LAG3), inducible co-stimulator (ICOS), programmed death-1 (PD-1), cytotoxic T-lymphocyte-associated protein-4 (CTLA-4), tumor necrosis factor receptor superfamily member-4 (TNFRSF4, OX40), and tumor necrosis factor receptor superfamily member-18 (TNFRSF18, GITR), but did not express Foxp3. CD8+ Treg-of-B cells produced higher concentration of inhibitory cytokine interleukin (IL)-10, and expressed higher levels of cytotoxic factor granzyme B and perforin after stimulation, compared to those of CD8+CD25- T cells. Moreover, CD8+ Treg-of-B cells suppressed T cell proliferation in vitro and alleviated colonic inflammation in chronic dextran sulfate sodium (DSS)-induced colitis. In conclusion, our study identified a novel subpopulation of CD8+ Tregs with suppressive effects through cell contact. These CD8+ Treg-of-B cells might have therapeutic potential for IBDs.
FoxO1 regulates TLR4/MyD88/MD2-NF-κB inflammatory signalling in mucosal barrier injury of inflammatory bowel disease.

Chenyang Han,Li Guo,Yongjia Sheng,Yi Yang,Jin Wang,Yanling Gu,Wenyan Li,Xiaohong Zhou,Qingcai Jiao

DOI: https://doi.org/10.1111/jcmm.15075

2020-01-01

Journal of Cellular and Molecular Medicine

Abstract:In this study, FoxO1 transgenic mice (transgenic, FoxO1-Tg) and C57BL/6 wild-type (wild-type, FoxO1-WT) mice were used to establish chronic colitis by drinking water containing dextran sulphate sodium (DSS). Afterwards, we observed the life changes in mice and assessed the pathological changes by H&E tissue staining. In addition, the TLR4/MyD88/MD2-NF-kappa B inflammatory signals were detected. As a result, under DSS treatment, the activation level of TLR4/MyD88/MD2-NF-kappa B inflammatory signal was higher in FoxO1-Tg mice than that in FoxO1-WT mice. Meanwhile, the intestinal mucosal tissue damage was more severe, the down-regulation of tight junction protein level was more significant and the life quality was decreased to a higher degree in FoxO1-Tg mice compared with those in FoxO1-WT mice. Caco-2 cells were used to mimic the intestinal mucosal barrier model for in vitro assays. In addition, lentiviral packaging FoxO1 overexpressing plasmid was transfected into Caco-2 cells for FoxO1 overexpression. TNF-alpha intervention was performed for intestinal mucosal inflammatory response model. Consequently, the down-regulation of FoxO1 inhibited the activation of TLR4/MyD88/MD2-NF-kappa B inflammatory signal, decreased the mucosal barrier permeability and up-regulated the expression of tight junction protein. By contrast, the overexpression of FoxO1 increased the mucosal barrier permeability and down-regulated the level of tight junction protein.
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity

Yann Cheli,Meri K. Tulic,Najla El Hachem,Nicolas Nottet,Arnaud Jacquel,Maeva Gesson,Thomas Strub,Karine Bille,Alexandra Picard-Gauci,Henri Montaudié,Guillaume E. Beranger,Thierry Passeron,Pierre Close,Corine Bertolotto,Robert Ballotti

DOI: https://doi.org/10.1186/s12943-021-01319-5

IF: 37.3

2021-01-27

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
[Corrigendum] FKBP11 protects intestinal epithelial cells against inflammation‐induced apoptosis via the JNK‐caspase pathway in Crohn's disease

Xiaotong Wang,Xiaopeng Cui,Chuanwu Zhu,Ming Li,Juan Zhao,Zhongyi Shen,Xiaohang Shan,Liang Wang,Han Wu,Yanting Shen,You Ni,Dongmei Zhang,Guoxiong Zhou

DOI: https://doi.org/10.3892/mmr.2024.13172

IF: 3.423

2024-01-27

Molecular Medicine Reports

Abstract:Subsequently to the publication of the above article, the authors realized that Fig. 4 in their paper had been assembled containing two erroneously placed gel slices; essentially, the GAPDH bands featured in Fig. 4A had also been included in Fig. 5, and the data for the FKBP11 bands in Fig. 4A had also been included to show the GRP78 bands in Fig. 4. The authors were able to revisit their original data and to correct the data that had been featured incorrectly in Fig. 4. The corrected version of Fig. 4, now showing the true data for the GRP78 protein bands in Fig. 4C and the correct GAPDH protein bands for Fig. 4A, is shown on the next page. Note that these errors did not significantly affect the results or the conclusions reported in this paper. All the authors agree to the publication of this Corrigendum, and are grateful to the Editor of Molecular Medicine Reports for allowing them the opportunity to correct this error. Moreover, the authors apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 18: 4428‐4438, 2018; DOI: 10.3892/mmr.2018.9485]

oncology,medicine, research & experimental
Correction to: Micronized sacchachitin promotes satellite cell proliferation through TAK1-JNK-AP-1 signaling pathway predominantly by TLR2 activation

Meng–Huang Wu,Chuang–Yu Lin,Chun–Yin Hou,Ming–Thau Sheu,Hsi Chang

DOI: https://doi.org/10.1186/s13020-020-00420-z

IF: 4.546

2021-02-04

Chinese Medicine

Abstract:An amendment to this paper has been published and can be accessed via the original article.

pharmacology & pharmacy,integrative & complementary medicine
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells

Xiangnan Guan,Ruozhen Hu,Yoonha Choi,Shyam Srivats,Barzin Y. Nabet,John Silva,Lisa McGinnis,Robert Hendricks,Katherine Nutsch,Karl L. Banta,Ellen Duong,Alexis Dunkle,Patrick S. Chang,Chia-Jung Han,Stephanie Mittman,Nandini Molden,Pallavi Daggumati,Wendy Connolly,Melissa Johnson,Delvys Rodriguez Abreu,Byoung Chul Cho,Antoine Italiano,Ignacio Gil-Bazo,Enriqueta Felip,Ira Mellman,Sanjeev Mariathasan,David S. Shames,Raymond Meng,Eugene Y. Chiang,Robert J. Johnston,Namrata S. Patil

DOI: https://doi.org/10.1038/s41586-024-07956-2

IF: 64.8

2024-08-22

Nature

Abstract:Nature - Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells

multidisciplinary sciences
TL1A blocking ameliorates intestinal fibrosis in the T cell transfer model of chronic colitis in mice

Hui Li,Jia Song,Guochao Niu,Hong Zhang,Jinbo Guo,David Q Shih,Stephan R Targan,Xiaolan Zhang

DOI: https://doi.org/10.1016/j.prp.2017.11.017

Abstract:Tumor necrosis factor like cytokine 1A (TL1A) is a member of the TNF superfamily. Accumulating evidence demonstrated the importance of TL1A in the pathogenesis of inflammatory bowel disease (IBD) and suggested a potential role of TL1A blocking in IBD therapy. Here we aimed to explore whether the anti-TL1A antibody could ameliorate intestinal inflammation and fibrosis in IBD. A T cell transfer model of chronic colitis was induced by intraperitoneal injection of CD4+CD45RBhigh naive T cells isolated from either C57BL/6 wild type (WT) mice or LCK-CD2-Tl1a-GFP transgenic (L-Tg) mice into recombinase activating gene-1-deficient (RAG-/-) mice. The colitis model mice were treated prophylactically or therapeutically with anti-Tl1a antibody or IgG isotype control. Haematoxylin and eosin staining (H&E staining), Masson's trichrome staining (MT staining) and sirius red staining were used to detect histopathological changes in colonic tissue; immunohistochemical staining was used to detect the expressions of collagen I, collagen III, TIMP1, vimentin, α-SMA and TGF-β1/Smad3. Results showed that anti-Tl1a antibody could reduce intestinal inflammation and fibrosis by inhibiting the activation of intestinal fibroblasts and reducing the collagen synthesis in the T cell transfer model of chronic colitis. The mechanism may be related to the inhibition of TGF-1/Smad3 signaling pathway.
HSF1 promotes CD69+ Treg differentiation to inhibit colitis progression

Lei Yu,Bingluo Zhou,Yiran Zhu,Ling Li,Yiming Zhong,Liyuan Zhu,Hanying Wang,Hui Chen,Jinye Xu,Tianxin Guo,Lifeng Feng,Xian Wang,Zhijian Cai,Jianli Wang,Hongchuan Jin

DOI: https://doi.org/10.7150/thno.78078

IF: 11.6

2023-03-21

Theranostics

Abstract:Regulatory T cells (Tregs) are critical for generating and maintaining peripheral tolerance. Treg-based immunotherapy is valuable for the clinical management of diseases resulting from dysregulation of immune tolerance. However, the lack of potency is a potential limitation of Treg therapy. In addition, CD69 positive-Treg (CD69+ Treg) represent a newly identified subset of Tregs with potent immune suppressive capability. Methods: Foxp3 YFP-Cre CD69 fl/fl and CD4 Cre CD69 fl/fl mice were generated to determine the relevance of CD69 to Treg. Chromatin Immunoprecipitation Assay (ChIP) and luciferase Assay were performed to detect the regulation of CD69 transcription by heat shock transcription factor 1(HSF1). Gene expression was measured by western blotting and qRT-PCR. The differentiation of naive T cells to CD69+Foxp3+ iTregs was determined by flow cytometry. The immunosuppressive ability of Tregs was analyzed by ELISA and flow cytometry. Colon inflammation in mice was reflected by changes in body weight and colon length, the disease activity index (DAI), and H&E staining of colon tissues. Results: Induced Tregs (iTregs) from CD4 Cre CD69 fl/fl mice failed to alleviate colitis. The transcription factor HSF1 interacted with the promoter of the CD69 gene to prompt its transcription during Treg differentiation. Genetic and chemical inhibition of HSF1 impaired CD69+ Treg differentiation and promoted the pathogenesis of colitis in mice. In contrast, HSF1 protein stabilized by inhibiting its proteasomal degradation promoted CD69+ Treg differentiation and alleviated colitis in mice. Moreover, adoptive transfer of iTregs with HSF1 stabilization by proteasome inhibitor (PSI) dramatically prevented the development of colitis in mice and was accompanied by decreased production of pro-inflammatory cytokines and reduced accumulation of pro-inflammatory lymphocytes in colitis tissue, whereas Tregs induced in the absence of PSI were less stable and ineffective in suppressing colitis. Conclusions: HSF1 promotes CD69+ Tregs differentiation by activating the CD69 transcription, which is critical for the immunosuppressive function of Tregs. Stabilization of HSF1 by PSIs results in the efficient generation of Tregs with high potency to treat colitis and probably other autoimmune diseases involving Tregs deficiency.
TGF Β1 Inhibits the Maturation of Dendritic Cells and Down- Regulates TLR4 Expression

MOU Hai-bo,LIN Mao-fang,CEN Hong,HUANG He

DOI: https://doi.org/10.3321/j.issn:1000-4718.2005.08.005

2005-01-01

Abstract:AIM: To investigate the effects of transforming growth factor β1 (TGF-β1) on murine-derived dendritic cells (DC). METHODS: Murine bone marrow cells were cultured with GM-CSF and TGF-β1 to develop TGF β-DC. Then they were stimulated by lipopolysaccharide (LPS). Their phenotypes were assessed by flow cytometry (FCM). The allogeneic stimulating capacity of DC was measured by mixed lymphocyte reaction (MLR) using BrdU ELISA method. IL-12 p70 protein was detected by ELISA and the expressions of Toll like receptor 4 (TLR4) on DCs were measured by semi-quantitative RT-PCR and FCM. RESULTS: Compared to immature DC (imDC) cultured with GM-CSF alone, the expressions of CD_80, CD_86, I-A~b and CD_40 in TGF β-DC were lower. The TGF β-DC was resistant to maturation by LPS. Maturation resistance was evident from a failure to up-regulate CMs, to stimulate larger T cell proliferation and to increase secretion of IL-12 p70. Down-regulation of TLR4 expression on TGF β-DC was also found. CONCLUSION: TGF-β1 inhibits the expression of co-stimulatory molecules on DC. It is resistant to maturation stimulus (LPS) and might be linked with TLR4 down-regulation.

Correction to: TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells

TGF-beta 1 gene -modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells (vol 7, pg 35, 2010)

TGF-|[bgr]|1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4|[plus]|Foxp3|[plus]| regulatory T cells

TGF-β1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4 + Foxp3 + regulatory T cells

Correction: Bifidobacterium Adolescentis Induces Decorin+ Macrophages Via TLR2 to Suppress Colorectal Carcinogenesis

Correction: Corrigendum: The transcriptional coactivator TAZ regulates reciprocal differentiation of T H 17 cells and T reg cells

Correction To: TAOK1 Negatively Regulates IL-17-mediated Signaling and Inflammation

Correction: Transdifferentiation of Tumor Infiltrating Innate Lymphoid Cells During Progression of Colorectal Cancer

Correction to: Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice

TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.

RETRACTED: Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes Dis DOI: 10.1016/J.gendis.2020.07.005]

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Characterization of novel CD8+ regulatory T cells and their modulatory effects in murine model of inflammatory bowel disease

FoxO1 regulates TLR4/MyD88/MD2-NF-κB inflammatory signalling in mucosal barrier injury of inflammatory bowel disease.

Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity

[Corrigendum] FKBP11 protects intestinal epithelial cells against inflammation‐induced apoptosis via the JNK‐caspase pathway in Crohn's disease

Correction to: Micronized sacchachitin promotes satellite cell proliferation through TAK1-JNK-AP-1 signaling pathway predominantly by TLR2 activation

Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T reg cells

TL1A blocking ameliorates intestinal fibrosis in the T cell transfer model of chronic colitis in mice

HSF1 promotes CD69+ Treg differentiation to inhibit colitis progression

TGF Β1 Inhibits the Maturation of Dendritic Cells and Down- Regulates TLR4 Expression

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]